Nomura Holdings Inc. lessened its holdings in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 77.5% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 14,637 shares of the real estate investment trust's stock after selling 50,499 shares during the quarter. Nomura Holdings Inc.'s holdings in Omega Healthcare Investors were worth $557,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in OHI. NBC Securities Inc. purchased a new position in shares of Omega Healthcare Investors in the 1st quarter worth about $29,000. Dunhill Financial LLC raised its stake in shares of Omega Healthcare Investors by 97.9% during the fourth quarter. Dunhill Financial LLC now owns 1,516 shares of the real estate investment trust's stock worth $57,000 after acquiring an additional 750 shares in the last quarter. CoreCap Advisors LLC lifted its holdings in shares of Omega Healthcare Investors by 177.3% in the 4th quarter. CoreCap Advisors LLC now owns 1,578 shares of the real estate investment trust's stock worth $60,000 after acquiring an additional 1,009 shares during the last quarter. Park Square Financial Group LLC purchased a new stake in shares of Omega Healthcare Investors in the 4th quarter valued at $61,000. Finally, UMB Bank n.a. grew its holdings in shares of Omega Healthcare Investors by 94.9% during the 1st quarter. UMB Bank n.a. now owns 2,175 shares of the real estate investment trust's stock valued at $83,000 after purchasing an additional 1,059 shares during the last quarter. 65.25% of the stock is currently owned by hedge funds and other institutional investors.
Insider Transactions at Omega Healthcare Investors
In other Omega Healthcare Investors news, Director Lisa Egbuonu-Davis sold 2,500 shares of the firm's stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $40.16, for a total value of $100,400.00. Following the completion of the sale, the director directly owned 18,654 shares in the company, valued at $749,144.64. This trade represents a 11.82% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 1.50% of the stock is currently owned by insiders.
Analyst Ratings Changes
OHI has been the subject of several recent research reports. Truist Financial boosted their price target on shares of Omega Healthcare Investors from $39.00 to $44.00 and gave the stock a "hold" rating in a research note on Wednesday. Scotiabank lifted their price objective on Omega Healthcare Investors from $39.00 to $42.00 and gave the stock a "sector perform" rating in a report on Thursday, August 28th. Royal Bank Of Canada increased their target price on Omega Healthcare Investors from $39.00 to $41.00 and gave the company a "sector perform" rating in a report on Thursday, August 7th. Wells Fargo & Company lifted their price target on Omega Healthcare Investors from $41.00 to $44.00 and gave the stock an "overweight" rating in a research note on Wednesday, August 27th. Finally, Raymond James Financial reiterated an "outperform" rating on shares of Omega Healthcare Investors in a research report on Tuesday, September 2nd. Five equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company's stock. According to MarketBeat, Omega Healthcare Investors presently has a consensus rating of "Moderate Buy" and an average price target of $43.38.
Check Out Our Latest Stock Analysis on OHI
Omega Healthcare Investors Trading Up 0.8%
Shares of OHI traded up $0.36 during mid-day trading on Friday, hitting $43.09. 1,467,660 shares of the company's stock traded hands, compared to its average volume of 1,958,922. The company has a quick ratio of 7.10, a current ratio of 7.10 and a debt-to-equity ratio of 0.96. The firm has a market capitalization of $12.71 billion, a P/E ratio of 26.60, a PEG ratio of 2.26 and a beta of 0.71. The business's 50-day moving average price is $39.64 and its 200-day moving average price is $38.03. Omega Healthcare Investors, Inc. has a 1 year low of $35.04 and a 1 year high of $44.42.
Omega Healthcare Investors (NYSE:OHI - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share for the quarter, beating the consensus estimate of $0.45 by $0.32. The business had revenue of $235.60 million for the quarter, compared to analysts' expectations of $248.49 million. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The firm's revenue for the quarter was up 11.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.71 earnings per share. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. As a group, sell-side analysts forecast that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current fiscal year.
Omega Healthcare Investors Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Monday, August 4th were given a dividend of $0.67 per share. The ex-dividend date was Monday, August 4th. This represents a $2.68 annualized dividend and a dividend yield of 6.2%. Omega Healthcare Investors's payout ratio is currently 165.43%.
Omega Healthcare Investors Company Profile
(
Free Report)
Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.
Featured Stories

Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.